Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cardiovasc. Med., 02 October 2025

Sec. Cardiovascular Epidemiology and Prevention

Volume 12 - 2025 | https://doi.org/10.3389/fcvm.2025.1672135

This article is part of the Research TopicInterdisciplinary Approaches to Physical Activity and Cardiovascular HealthView all articles

Leisure-time physical activity, daily sitting time, and risk of mortality among CVD patients: a prospective cohort study


Changnan Xu,&#x;Changnan Xu1,†Kai Jin,&#x;Kai Jin2,†Yike SunYike Sun3Mengbiao CaiMengbiao Cai1Jian ZhuJian Zhu1Yi Yang

Yi Yang4*
  • 1Physical Education Department, Nanjing University of Aeronautics and Astronautics, Nanjing, China
  • 2Department of Physical Education, Southeast University, Nanjing, China
  • 3Sports Coaching College, Beijing Sport University, Beijing, China
  • 4College of Physical Education, Qingdao Hengxing University of Science and Technology, Qingdao, China

Background: Cardiovascular disease (CVD) is a leading cause of mortality globally. While leisure time physical activity (LTPA) and daily sitting time (DST) are known modulators of health, their combined impact on mortality risk specifically among CVD patients warrants further investigation. This study aimed to examine the independent and joint associations of LTPA and DST with mortality in a nationally representative sample of US adults with CVD.

Methods: This prospective cohort study included 2,335 adults with CVD (weighted mean age 61.56 years; 57.12% male) from the National Health and Nutrition Examination Survey (NHANES) 2007–2018, followed for a median of 5.75 years. LTPA was categorized as inactive (0 min/week), insufficiently active (1–<150 min/week), and sufficiently active (≥150 min/week). DST was categorized as 0–<6, 6–<8, and ≥8 h/days. Mortality data were obtained through linkage to the National Death Index until December 31, 2019. Cox proportional hazards models estimated hazard ratios (HRs) and 95% confidence intervals (CIs), adjusting for covariates.

Results: Over 14,139 person-years, 552 deaths (197 CVD-related) occurred. Sufficient LTPA (≥150 min/week) was associated with reduced risks of all-cause (HR: 0.45, 95% CI: 0.31–0.66, P < 0.001), CVD (HR: 0.51, 95% CI: 0.25–1.02, P = 0.058), and non-CVD mortality (HR: 0.43, 95% CI: 0.28–0.65, P < 0.001). Per 60 min/week increase in weekly LTPA was associated with 10% (HR: 0.90, 95% CI: 0.85–0.95) lower risk of all-cause mortality, 12% (HR: 0.88, 95% CI: 0.79–0.97) lower risk of CVD mortality, and 9% (HR: 0.91, 95% CI: 0.84–0.98) lower risk of non-CVD mortality, respectively. DST ≥8 h/days increased risks of all-cause (HR: 1.89, 95% CI: 1.50–2.37, P < 0.001), CVD (HR: 2.22, 95% CI: 1.51–3.26, P < 0.001), and non- CVD mortality (HR: 1.75, 95% CI: 1.29–2.36, P < 0.001) compared to <6 h/days. Combined analyses showed the lowest mortality risk in sufficiently active individuals with DST <6 h/days (all-cause HR: 0.27, 95% CI: 0.18–0.41, P < 0.001).

Conclusion: This study suggests that increasing leisure-time physical activity and reducing sedentary time may have potential benefits for reducing mortality in patients with CVD.

Introduction

Cardiovascular disease (CVD) stands as the primary cause of morbidity and mortality globally, imposing a substantial burden on individuals, healthcare systems, and societies (1). Effective secondary prevention strategies are crucial for improving the prognosis and quality of life for those with CVD. Among these strategies, lifestyle adjustments play a pivotal role, with physical activity serving as a cornerstone (2). Leisure-time physical activity (LTPA), encompassing activities performed during discretionary time, has been consistently linked to numerous health benefits, including reduced risk of premature mortality in the general population and in individuals with chronic conditions such as cancer and type 2 diabetes (24). Recognizing these benefits, public health recommendations, like the 2018 Physical Activity Guidelines for Americans, suggest that adults engage in at least 150 min of physical activity per week, or an equivalent mix, to attain significant health advantages. However, a substantial number of adults worldwide fail to meet these fundamental activity guidelines, perpetuating the persistent public health issue.

In addition to concerns regarding physical inactivity, there is a growing acknowledgment of sedentary behavior as a distinct health hazard. Sedentary behavior is defined as any waking behavior with an energy expenditure of ≤1.5 metabolic equivalents (METs) while in a sitting, reclining, or lying position (5). Common examples of sedentary behaviors include watching television, using computers, and prolonged sitting during work (6, 7). Modern lifestyles, characterized by increased screen time, reliance on motorized transportation, and sedentary occupations, have resulted in unprecedented levels of daily sitting time (DST) among populations (8). Prolonged sitting has been identified as an independent risk factor for overall mortality, CVD mortality, and cancer mortality (9). Importantly, sedentary behavior is not simply the lack of physical activity; individuals can adhere to physical activity guidelines while still accumulating significant sedentary time, a phenomenon sometimes termed the “active couch potato” (10).

The individual impacts of LTPA and DST on health outcomes are well-documented. However, further investigation is needed to understand the interaction between these factors, particularly in individuals with established CVD. Previous studies have explored the combined effects of physical activity and sedentary behavior on mortality in the general population (11), as well as in specific patient groups such as cancer survivors (3, 12) and stroke survivors (13). These studies suggest that high levels of physical activity may partially mitigate the risks associated with prolonged sitting. Nonetheless, there is a lack of comprehensive data on these combined effects within a diverse cohort of CVD patients from a nationally representative sample. A deeper understanding of how the interplay between LTPA and DST influences mortality risk in this vulnerable population can provide more nuanced public health recommendations and inform targeted interventions (14).

This study aimed to investigate the separate and combined associations of LTPA and DST with all-cause, CVD, and non-CVD mortality in a nationally representative sample of US adults with pre-existing CVD. It was hypothesized that higher LTPA levels and lower DST would be independently linked to reduced mortality risk, and that individuals with high LTPA and low DST levels would exhibit the lowest mortality risk.

Methods

Study participants

NHANES, a nationally representative program of surveys designed to assess the health and nutritional status of adults and children in US, examined approximately 5,000 non-institutional civilians each year. NHANES was approved by the National Center for Health Statistics (NCHS) Ethics Review Board and had obtained informed consents from participants.

A total of 32,016 non-pregnant adults (20–79 years) from NHANES 2007–2018 cycles were selected for eligibility screening. We excluded 133 subjects with missing mortality information, 42 subjects without LTPA data, and 156 subjects without DST data, with 31,705 subjects left. Moreover, 29,370 participants free of CVD and 647 subjects with missing covariates were excluded. Those who answered yes to the questions “Has a doctor or other health professional ever told you that you had congestive heart failure, coronary heart disease, angina/angina pectoris, heart attack, or stroke?” were identified as CVD patients. Finally, the current prospective cohort study comprised 2,335 CVD patients, and the flow of eligibility screening was shown in Supplementary Figure S1.

Leisure-time physical activity and daily sitting time

LTPA and DST were collected with the Global Physical Activity Questionnaire. Participants were asked to report the frequency and duration of moderate and vigorous LTPA over the past week with questions “In a typical week, on how many days do you do vigorous/moderate-intensity sports, fitness or recreational activities?” and “How much time do you spend doing vigorous/moderate-intensity sports, fitness or recreational activities on a typical day?”. In this study, the amount of LTPA was determined by the total weekly minutes of moderate-to-vigorous activity reported by participants, calculated as: total LTPA = moderate activity (minutes per week) + 2*vigorous activity (min per week) (13). The time spent in LTPA as summarized and participants were classified as inactive (0 min/week), insufficiently active (1–<150 min/week), and sufficiently active (≥150 min/week), according to the 2018 Physical Guidelines for Americans (15). Participants were also asked “How much time do you usually spend sitting on a typical day?”. Sitting time was defined as daily time spent sitting at work, at home, getting to and from places, or with friends, including time spent sitting at a desk, traveling in a car or bus, reading, playing cards, watching television, or using a computer. In accordance with recent studies, DST was categorized into 3 groups: 0–<6, 6–<8, and ≥8 h/days (3, 13).

Outcome assessment

The outcomes of interest in our study were all-cause, CVD, and non-CVD mortality, which were identified through linkage to the National Death Index until December 31, 2019. Causes of death had been ascertained according to the International Classification of Diseases, Tenth Revision (ICD-10) by the NCHS. In the current prospective cohort study, CVD deaths were defined as deaths attributed to heart disease or cerebrovascular disease (ICD codes I00-I09, I11, I13, I20-I51, I60-I69). Non-CVD deaths included deaths attributable to malignant neoplasms, chronic lower respiratory diseases, accidents, diabetes, influenza and pneumonia, nephritis, nephrotic syndrome and nephrosis, and all other causes. Follow-up duration was defined as the interval from the mobile examination center date to the date of death or December 31, 2019, whichever occurred first.

Covariates

Demographic, socioeconomic, lifestyle information was collected with a computer-assisted personal interview system by trained interviewers. Covariates were selected based on established associations with physical activity, sedentary behavior, and mortality, including age, sex, race/ethnicity, obesity, marital status, education, income, smoking, alcohol use, hypertension, diabetes, and hypercholesterolemia (13). Race/ethnicity was categorized as non-Hispanic white, non-Hispanic black, Mexican American, and others. Body mass index (BMI) was calculated as weight (kg) divided by height (m) squared. Those with BMI ≥ 30.0 kg/m2 were considered as obese. Marital status was categorized as married, single (widowed, divorced, separated, never married), and living with partner. Self-reported education attainment was grouped as under high school, high school, and above high school. Family poverty-income ratio (PIR), which was calculated by dividing family (or individual) income by the poverty guidelines specific to the survey year, was applied to measure income status. Current smoking was defined as smoking cigarettes when surveyed. Current drinking was defined as consuming any type of alcoholic beverage in the past 12 months. Blood pressure measurements were collected by examiners with mercury sphygmomanometers. Hypertension was defined as systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, physician-diagnosed hypertension, or currently taking prescribed medicine for hypertension. Diabetes was defined as fasting plasma glucose (FPG) ≥ 126 mg/dl, glycated hemoglobin A1c (HbA1c) ≥6.5%, self-reported physician-diagnosed diabetes, use of insulin or oral hypoglycemic medication. Hypercholesterolemia was defined as total cholesterol (TC) ≥240 mg/dl, physician-diagnosed hypercholesterolemia, or currently taking prescribed medicine for hypercholesterolemia.

Statistical methods

Taking the complex, multistage, and probability sampling design of NHANES into account, we applied sampling weights and sample design variables in analyses. We selected the MEC exam weight (wtmec2yr) and combined the cycles with the recommended methods (https://wwwn.cdc.gov/nchs/nhanes/tutorials/Weighting.aspx). Continuous variables were expressed with weighted means and standard errors (SEs), and categorical variables were expressed with numbers and weighted percentages. Population characteristics across LTPA and DST groups were compared with linear regression for continuous variables and logistic regression for categorical variables.

The log-rank test and Kaplan–Meier (K-M) survival analysis were used to investigate differences in survival probabilities across LTPA and DST groups. Cox proportional hazards regression model was applied to examine the association between LTPA and DST and mortality risk. The proportional hazards assumptions were tested with Schoenfeld residuals method, and no violation was observed (Supplementary Table S1). In model 1, we adjusted age (<60, ≥ 60 years), sex (male, female), and race/ethnicity (non-Hispanic white, others). In model 2, we further adjusted for obesity (yes, no), marital status (married, others), family poverty-income ratio (<3.5, ≥3.5), education attainment (above high school, high school and below), current smoking (yes, no), current drinking (yes, no), hypertension (yes, no), diabetes (yes, no), and hypercholesterolemia (yes, no). To examine whether the associations between LTPA and DST and mortality risk differed by age, sex, race/ethnicity, obesity, marital status, education attainment, family PIR, smoking, alcohol drinking, hypertension, diabetes, and hypercholesterolemia, we performed stratified and interaction analyses. To investigate the joint effect, participants were categorized based on PA and DST, KM survival analysis as well as multivariable Cox proportional hazards regression models were used to estimate mortality risk. We performed the following sensitivity analyses to evaluate the robustness of our results. We excluded deaths that occurred within the first one year of follow-up. In addition, we calculated an assessment of potential residual confounding with E-values, defined as the minimum strength of association on the HR scale that an unmeasured confounder would need to have with both the exposure and the outcome to fully explain away the observed exposure-outcome association, conditional on the measured covariates (16, 17).

All statistical analyses were conducted with R version 4.4.2 (The R Foundation for Statistical Computing, Vienna, Austria). Two-sided P-values <0.05 were considered as statistical significance.

Results

Population characteristics

A total of 2,335 CVD patients (weighted mean age 61.56 years and 57.12% male) were comprised in this prospective cohort study (Table 1). Those with sufficiently active LTPA levels were more likely to be male, non-Hispanic white, married, well-educated, had better income status, current non-smokers, current drinkers, and less likely to have obesity, hypertension, and diabetes (all P < 0.05) (Table 1). More daily sitting time was found in those with inactive LTPA levels (P < 0.001) (Table 1). Those with higher DST levels were more likely to be older, obesity, non-Hispanic white, diabetic, and physically inactive (all P < 0.05) (Supplementary Table S2).

Table 1
www.frontiersin.org

Table 1. Characteristics of the study population according to the levels of leisure-time physical activity.

Associations between LTPA and DST and risk of mortality among CVD patients

During 14,139 person-years of follow-up (median follow-up, 5.75 years), a total of 552 deaths, of which 197 died of CVD, were ascertained. The Kaplan–Meier (K-M) survival analysis demonstrated significant differences in all-cause, CVD, and non-CVD mortality rates across levels of LTPA and DST (all log-rank tests P< 0.001) (Figures 1,2). After adjusting for all covariates, per hour increase in weekly LTPA was associated with 10% (HR: 0.90, 95% CI: 0.85–0.95) lower risk of all-cause mortality, 12% (HR: 0.88, 95% CI: 0.79–0.97) lower risk of CVD mortality, and 9% (HR: 0.91, 95% CI: 0.84–0.98) lower risk of non-CVD mortality, respectively (Table 2). Moreover, compared with those with DST < 6 h/days, subjects with DST ≥8 h/days were faced with 7% (HR: 1.07, 95% CI: 1.04–1.11) greater risk of all-cause mortality, 9% (HR: 1.09, 95% CI: 1.05–1.13) greater risk of CVD mortality, and 6% (HR: 1.06, 95% CI: 1.02–1.10) greater risk of non-CVD mortality, respectively (Table 2). To investigate whether the associations between LTPA and DST and mortality risk differed by age, sex, race/ethnicity, obesity, marital status, education attainment, family PIR, smoking, alcohol drinking, hypertension, diabetes, and hypercholesterolemia, we performed stratified and interaction analyses and observed no significant interactions, with all P-interaction >0.05 (Supplementary Tables S3–S8).

Figure 1
Three Kaplan-Meier survival curves labeled A, B, and C, comparing survival probabilities over 12 years based on leisure-time physical activity (LTPA) in minutes. Groups are 0 minutes (red), 1-149 minutes (green), and 150 or more minutes (blue). All graphs show higher survival probability for increased physical activity. Statistical significance is indicated with p-values less than 0.001.

Figure 1. Kaplan-Meier survival curves for mortality, stratified by levels of leisure-time physical activity. (A) All-cause mortality; (B) CVD mortality; (C) non-CVD mortality. LTPA, leisure-time physical activity.

Table 2
www.frontiersin.org

Table 2. The associations of leisure-time physical activity and daily sitting time with all-cause, CVD, and non-CVD mortality among CVD patients.

Joint associations between LTPA and DST and risk of mortality among CVD patients

The survival rates of all-cause, CVD, and non-CVD mortality were significantly different among the four groups (all log-rank tests P < 0.001), with the highest survival rates observed for sufficiently active individuals who sat <6 h/days (Figures 3,4). Compared with the referent group (those sitting ≥8 h/days and physically inactive), sufficiently active subjects with sitting <6 h/days were confronted with 73% (HR: 0.27, 95% CI: 0.18–0.41) lower risk of all-cause mortality, 76% (HR: 0.24, 95% CI: 0.12–0.48) lower risk of CVD mortality, and 72% (HR: 0.28, 95% CI: 0.17–0.47) lower risk of non-CVD mortality, respectively (Table 3).

Figure 2
Kaplan-Meier survival curves in panels A, B, and C, each showing time in years versus survival probability for three groups: DST less than six hours (red), six to eight hours (green), and greater than eight hours (blue). Each panel indicates different p-values: A (p<0.001), B (p=0.003), C (p=0.001), with corresponding data tables below.

Figure 2. Kaplan-Meier survival curves for mortality, stratified by levels of daily sitting time. (A) All-cause mortality; (B) CVD mortality; (C) non-CVD mortality. DST, daily sitting time.

Figure 3
Three Kaplan-Meier survival curves (A, B, C) display survival probabilities over time in years, categorized by joint categories LTPA and DST levels. Each curve shows distinct colors representing different groups. The x-axis represents time in years, and the y-axis shows survival probability. All panels indicate significant differences with p-values less than 0.001. Corresponding tables below each graph show the number of participants at risk at different time points for each category.

Figure 3. Kaplan-Meier survival curves for mortality, stratified by joint variables of leisure-time physical activity and daily sitting time. (A) All-cause mortality; (B) CVD mortality; (C) non-CVD mortality. DST, daily sitting time; LTPA, leisure-time physical activity.

Figure 4
Forest plot illustrating odds ratios (ORs) for all-cause, cardiovascular (CVD), and non-CVD mortality across four physical activity and sedentary time groups. Groups include varying levels of leisure-time physical activity (LTPA) and daily sedentary time (DST). ORs and confidence intervals (CIs) are shown with corresponding P-interaction values. The plot features squares for ORs and horizontal lines for CIs, with a reference value set at one.

Figure 4. The forest plot of joint analysis.

Table 3
www.frontiersin.org

Table 3. Joint associations of leisure-time physical activity and daily sitting time with mortality among CVD patients.

Sensitivity analyses

The observed significant associations after excluding early deaths occurring in the first one year of follow-up. Compared with physically inactive individuals, sufficiently active individuals were faced with 11% (HR: 0.89, 95% CI: 0.83–0.96) lower risk of all-cause mortality, 14% (HR: 0.86, 95% CI: 0.77–0.97) lower risk of CVD mortality, and 9% (HR: 0.91, 95% CI: 0.84–0.98) lower risk of non-CVD mortality, respectively (Supplementary Table S9). Compared with those with DST < 6 h/days, subjects with sitting ≥8 h/days were faced with 94% (HR: 1.94, 95% CI: 1.53–2.46) higher risk of all-cause mortality, 135% (HR: 2.35, 95% CI: 1.55–3.54) higher risk of CVD mortality, and 77% (HR: 1.77, 95% CI: 1.31–2.40) higher risk of non-CVD mortality, respectively (Supplementary Table S9). Per hour increase in DST was associated with 7% (HR: 1.07, 95% CI: 1.03–1.10) greater risk of all-cause mortality, 9% (HR: 1.09, 95% CI: 1.05–1.13) greater risk of CVD mortality, and 5% (HR: 1.05, 95% CI: 1.01–1.10) greater risk of non-CVD mortality, respectively (Supplementary Table S9). Moreover, significantly decreased risks of mortality were found in sufficiently active subjects with sitting <6 h/days, compared with the referent group (Supplementary Table S10). Compared with the referent group (those sitting ≥8 h/days and physically inactive), sufficiently active subjects with sitting <6 h/days were confronted with 74% (HR: 0.26, 95% CI: 0.17–0.40) lower risk of all-cause mortality, 80% (HR: 0.20, 95% CI: 0.09–0.44) lower risk of CVD mortality, and 71% (HR: 0.29, 95% CI: 0.17–0.48) lower risk of non-CVD mortality, respectively (Supplementary Table S10). The E-values suggested that it would take strong confounding to negate the significant associations observed in our study (Supplementary Table S11).

Discussion

This prospective cohort study, utilizing a nationally representative sample of US adults with pre-existing CVD, establishes that higher levels of LTPA and lower DST are independently linked to significantly decreased risks of all-cause, CVD, and non-CVD mortality. Notably, the combined analysis indicates that individuals engaging in sufficient activity and sitting for under 6 h daily exhibit the lowest mortality risk, with a substantial reduction exceeding 70% compared to inactive individuals sitting for 8 or more hours daily. These results underscore the crucial roles of increasing physical activity and reducing sedentary time in the secondary prevention of mortality among CVD patients.

The independent association of LTPA with reduced mortality risk in our CVD cohort is consistent with existing evidence in the general population (1820), as well as in other patient groups such as those with type 2 diabetes (2, 21) and cancer survivors (3, 12). Our finding that each additional hour of weekly LTPA is linked to a 10%–12% decrease in mortality risk highlights the dose-response relationship of physical activity. Even inadequate activity levels (1–<150 min/week) show a potential decrease in risk compared to being entirely inactive, although meeting or exceeding 150 min/week provides the most significant benefits, in line with current physical activity guidelines (22, 23).

Similarly, the associations of prolonged DST observed in our study are well-documented. Higher DST has been associated with elevated all-cause and CVD mortality rates across various populations (2426). Specifically, in individuals with CVD such as stroke survivors, sitting for ≥8 h per day has been linked to increased mortality risk (13). Our results, indicating a 7% higher risk of all-cause mortality for each additional hour of DST and a 45% increased risk for those sitting ≥8 h per day compared to <6 h per day, emphasize the importance of reducing sedentary time as a critical health goal for CVD patients (8). The average individual may spend a considerable portion of their day in a sedentary state (27), with older adults averaging 9.4 h of sedentary behavior daily (5).

Our study's most significant finding is the combined associations of LTPA and DST on mortality. Individuals engaging in adequate physical activity and maintaining low DST (<6 h/day) demonstrated the lowest mortality risk, indicating a synergistic advantage. This aligns with previous research, such as a study on stroke survivors showing that active individuals sitting <6 h/day had notably lower all-cause mortality risk compared to inactive individuals sitting ≥8 h/day (13). Similarly, research on cancer survivors by Cao (2022) and Yu (2023) found that being physically active and sitting less correlated with improved survival rates (3, 28). Our study expands on these findings to a wider CVD population. However, among those with high DST (≥8 h/day), meeting recommended activity levels did not show a statistically significant mortality reduction compared to being inactive with high DST (all-cause HR: 0.85, 95% CI: 0.46–1.60; CVD HR: 0.96, 95% CI: 0.32–2.87; non-CVD HR: 0.79, 95% CI: 0.38–1.66), though the point estimates suggest a potential protective effect. This finding contrasts with prior evidence, including a comprehensive meta-analysis (29), indicating that adequate physical activity can partially offset the risks of prolonged sedentary behavior. Possible explanations for this discrepancy include the smaller sample size in the high DST and sufficient LTPA subgroup (n = 131), leading to wide confidence intervals and reduced statistical power; the specific vulnerability of CVD patients, who may require higher activity thresholds to mitigate sedentary risks; or limitations in self-reported measures, which could introduce misclassification bias. Conversely, among inactive individuals, lower DST was associated with better survival outcomes, highlighting the benefits of reducing sitting time even if activity guidelines are not fully met. Studies on occupational sitting further suggest that high levels of LTPA can mitigate the risks linked to prolonged sitting during work hours (11, 30), which is relevant here as DST in our study encompasses both leisure and occupational sitting time. However, it is essential to acknowledge that occupational physical activity (OPA) may not yield the same cardiovascular health advantages as leisure-time physical activity (31, 32), underscoring why our focus on LTPA is particularly pertinent for CVD patients, where intentional, moderate-to-vigorous activity may be more beneficial than incidental OPA.

Physical activity has diverse effects on cardiovascular health, including enhancing endothelial function, reducing inflammation, improving insulin sensitivity, lowering blood pressure, optimizing lipid profiles, and aiding in weight management (33). In contrast, prolonged sitting is linked to adverse metabolic outcomes such as impaired glucose metabolism, elevated triglycerides, and decreased HDL cholesterol, possibly due to reduced muscle contractile activity and its effects on lipoprotein lipase function (7, 34). Sedentary behavior can also result in increased arterial stiffness and compromised vascular function (27). The combination of regular physical activity and reduced sitting time likely optimizes these physiological pathways, thereby enhancing cardiovascular health and longevity. Moreover, physical activity can influence body fat distribution, which is associated with mortality rates (3537).

Our study possesses several strengths. Firstly, it utilized data from NHANES, a large, nationally representative sample of US adults, thereby enhancing the generalizability of our findings to the US CVD population. Secondly, the prospective cohort design enabled the examination of temporal relationships between LTPA, DST, and mortality. Thirdly, mortality outcomes were determined through linkage to the NDI, ensuring precise and comprehensive data.

Several limitations need to be acknowledged. Firstly, the self-reported nature of LTPA and DST may introduce recall bias and social desirability bias, potentially leading to misclassification (38). The utilization of objective measures, such as accelerometers, would offer more precise assessments. Secondly, LTPA and DST were only evaluated at baseline, failing to capture changes in these behaviors over the follow-up period, which could impact the associations. Thirdly, despite adjusting for numerous covariates, the possibility of residual confounding by unmeasured factors (e.g., medication adherence, severity of CVD) remains, although E-values indicate substantial robustness. Fourthly, the observational design of the study prevents definitive causal inferences. Fifthly, the definition of CVD relied on self-reported physician diagnosis, introducing a potential misclassification bias.

The implications of our findings for clinical and public health are substantial. For patients with CVD, who face a high risk of subsequent events and mortality, promoting LTPA and reducing DST should be key components of secondary prevention strategies. Healthcare providers should regularly evaluate and advise CVD patients on both behaviors. Interventions should not only focus on structured exercise programs but also on integrating more movement into daily activities and breaking up prolonged periods of sitting. Public health campaigns should stress the importance of “moving more and sitting less” for this vulnerable population. Even for patients struggling to meet recommended LTPA levels, reducing DST can still yield survival benefits. Future clinical intervention studies are required to confirm the findings of this study and offer more robust evidence. Studies incorporating objective measures of activity and sedentary time would be valuable. Furthermore, examining different types and domains of physical activity (e.g., occupational, transport-related) and sedentary behaviors (e.g., TV viewing, computer use) could offer additional insights.

Conclusion

In conclusion, this study suggests that increasing leisure-time physical activity and reducing sedentary time may have potential benefits for reducing mortality in patients with cardiovascular disease. Future research should incorporate objective measures, such as accelerometers, for assessing LTPA and DST to mitigate self-report biases and validate these associations. Additionally, randomized controlled intervention trials are needed to establish causality, evaluate the long-term effects of targeted programs promoting physical activity and reducing sitting time, and explore the impacts of different domains (e.g., occupational, transport-related) and types (e.g., screen-based vs. non-screen) of these behaviors on mortality outcomes in diverse CVD populations.

Data availability statement

Publicly available datasets were analyzed in this study. This data can be found here: The datasets utilized or examined in this study can be accessed at https://www.cdc.gov/nchs/nhanes/?CDC_AAref_Val=https://www.cdc.gov/nchs/nhanes/index.htm.

Ethics statement

The studies involving humans were approved by The NHANES surveys and examinations obtained written informed consent from all participants after receiving approval from the National Center for Health Statistics Research Ethics Review Board. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants' legal guardians/next of kin.

Author contributions

CX: Conceptualization, Data curation, Investigation, Software, Writing – original draft. KJ: Conceptualization, Investigation, Data curation, Software, Writing – original draft. YS: Conceptualization, Investigation, Writing – original draft. MC: Conceptualization, Investigation, Writing – original draft. JZ: Conceptualization, Investigation, Writing – original draft. YY: Conceptualization, Data curation, Investigation, Methodology, Supervision, Writing – review & editing.

Funding

The author(s) declare that no financial support was received for the research and/or publication of this article.

Acknowledgments

The authors acknowledge the researchers, the Centers for Disease Control and Prevention, and the participants of the NHANES studies for their contributions.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declare that no Generative AI was used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcvm.2025.1672135/full#supplementary-material

References

1. He J, Bundy JD, Geng S, Tian L, He H, Li X, et al. Social, behavioral, and metabolic risk factors and racial disparities in cardiovascular disease mortality in U.S. Adults: an observational study. Ann Intern Med. (2023) 176(9):1200–8. doi: 10.7326/M23-0507

PubMed Abstract | Crossref Full Text | Google Scholar

2. Tarp J, Luo M, Sanchez-Lastra MA, Dalene KE, Cruz BDP, Ried-Larsen M, et al. Leisure-time physical activity and all-cause mortality and cardiovascular disease in adults with type 2 diabetes: cross-country comparison of cohort studies. J Sport Health Sci. (2024) 13(2):212–21. doi: 10.1016/j.jshs.2023.10.004

PubMed Abstract | Crossref Full Text | Google Scholar

3. Cao C, Friedenreich CM, Yang L. Association of daily sitting time and leisure-time physical activity with survival among US cancer survivors. JAMA Oncol. (2022) 8(3):395–403. doi: 10.1001/jamaoncol.2021.6590

PubMed Abstract | Crossref Full Text | Google Scholar

4. Zhao M, Veeranki SP, Li S, Steffen LM, Xi B. Beneficial associations of low and large doses of leisure time physical activity with all-cause, cardiovascular disease and cancer mortality: a national cohort study of 88,140 US adults. Br J Sports Med. (2019) 53(22):1405–11. doi: 10.1136/bjsports-2018-099254

PubMed Abstract | Crossref Full Text | Google Scholar

5. Harvey JA, Chastin SF, Skelton DA. How sedentary are older people? A systematic review of the amount of sedentary behavior. J Aging Phys Act. (2015) 23(3):471–87. doi: 10.1123/japa.2014-0164

PubMed Abstract | Crossref Full Text | Google Scholar

6. Hadgraft NT, Lynch BM, Clark BK, Healy GN, Owen N, Dunstan DW. Excessive sitting at work and at home: correlates of occupational sitting and TV viewing time in working adults. BMC Public Health. (2015) 15:899. doi: 10.1186/s12889-015-2243-y

PubMed Abstract | Crossref Full Text | Google Scholar

7. Sisson SB, Camhi SM, Church TS, Martin CK, Tudor-Locke C, Bouchard C, et al. Leisure time sedentary behavior, occupational/domestic physical activity, and metabolic syndrome in U.S. Men and women. Metab Syndr Relat Disord. (2009) 7(6):529–36. doi: 10.1089/met.2009.0023

PubMed Abstract | Crossref Full Text | Google Scholar

8. Chrysant SG, Chrysant GS. The cardiovascular consequences of excess sitting time. J Clin Hypertens (Greenwich). (2015) 17(7):528–31. doi: 10.1111/jch.12519

PubMed Abstract | Crossref Full Text | Google Scholar

9. Li S, Lear SA, Rangarajan S, Hu B, Yin L, Bangdiwala SI, et al. Association of sitting time with mortality and cardiovascular events in high-income, middle-income, and low-income countries. JAMA Cardiol. (2022) 7(8):796–807. doi: 10.1001/jamacardio.2022.1581

PubMed Abstract | Crossref Full Text | Google Scholar

10. Gubelmann C, Vollenweider P, Marques-Vidal P. Of weekend warriors and couch potatoes: socio-economic determinants of physical activity in Swiss middle-aged adults. Prev Med. (2017) 105:350–5. doi: 10.1016/j.ypmed.2017.10.016

PubMed Abstract | Crossref Full Text | Google Scholar

11. Gao W, Sanna M, Chen YH, Tsai MK, Wen CP. Occupational sitting time, leisure physical activity, and all-cause and cardiovascular disease mortality. JAMA Netw Open. (2024) 7(1):e2350680. doi: 10.1001/jamanetworkopen.2023.50680

PubMed Abstract | Crossref Full Text | Google Scholar

12. Cao C, Wang N, Liu R, Patel AV, Friedenreich CM, Yang L. Leisure-time physical activity, daily sitting time, and mortality among US skin cancer survivors. Support Care Cancer. (2023) 31(12):718. doi: 10.1007/s00520-023-08192-637999788

PubMed Abstract | Crossref Full Text | Google Scholar

13. Yu C, Cao Y, Liu Q, Tan H, Xia G, Chen B, et al. Sitting time, leisure-time physical activity, and risk of mortality among US stroke survivors: a prospective cohort study from the NHANES 2007 to 2018. Stroke. (2025) 56(7):1738–47. doi: 10.1161/STROKEAHA.124.049672

PubMed Abstract | Crossref Full Text | Google Scholar

14. Franklin BA, Brinks J, Sternburgh L. Move more, sit less: a first-line, public health preventive strategy? Prev Cardiol. (2010) 13(4):203–8. doi: 10.1111/j.1751-7141.2010.00075.x

PubMed Abstract | Crossref Full Text | Google Scholar

15. Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, et al. The physical activity guidelines for Americans. Jama. (2018) 320(19):2020–8. doi: 10.1001/jama.2018.14854

PubMed Abstract | Crossref Full Text | Google Scholar

16. VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. (2017) 167(4):268–74. doi: 10.7326/M16-2607

PubMed Abstract | Crossref Full Text | Google Scholar

17. Blum MR, Tan YJ, Ioannidis JPA. Use of E-values for addressing confounding in observational studies-an empirical assessment of the literature. Int J Epidemiol. (2020) 49(5):1482–94. doi: 10.1093/ije/dyz261

PubMed Abstract | Crossref Full Text | Google Scholar

18. Arem H, Moore SC, Patel A, Hartge P, Berrington de Gonzalez A, Visvanathan K, et al. Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship. JAMA Intern Med. (2015) 175(6):959–67. doi: 10.1001/jamainternmed.2015.0533

PubMed Abstract | Crossref Full Text | Google Scholar

19. Moore SC, Patel AV, Matthews CE, Berrington de Gonzalez A, Park Y, Katki HA, et al. Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis. PLoS Med. (2012) 9(11):e1001335. doi: 10.1371/journal.pmed.1001335

PubMed Abstract | Crossref Full Text | Google Scholar

20. Barengo NC, Hu G, Lakka TA, Pekkarinen H, Nissinen A, Tuomilehto J. Low physical activity as a predictor for total and cardiovascular disease mortality in middle-aged men and women in Finland. Eur Heart J. (2004) 25(24):2204–11. doi: 10.1016/j.ehj.2004.10.009

PubMed Abstract | Crossref Full Text | Google Scholar

21. He D, Xi B, Xue J, Huai P, Zhang M, Li J. Association between leisure time physical activity and metabolic syndrome: a meta-analysis of prospective cohort studies. Endocrine. (2014) 46(2):231–40. doi: 10.1007/s12020-013-0110-0

PubMed Abstract | Crossref Full Text | Google Scholar

22. Thompson PD, Baggish AL, Franklin B, Jaworski C, Riebe D. American College of sports medicine expert consensus statement to update recommendations for screening, staffing, and emergency policies to prevent cardiovascular events at health fitness facilities. Curr Sports Med Rep. (2020) 19(6):223–31. doi: 10.1249/JSR.0000000000000721

PubMed Abstract | Crossref Full Text | Google Scholar

23. Geidl W, Schlesinger S, Mino E, Miranda L, Pfeifer K. Dose-response relationship between physical activity and mortality in adults with noncommunicable diseases: a systematic review and meta-analysis of prospective observational studies. Int J Behav Nutr Phys Act. (2020) 17(1):109. doi: 10.1186/s12966-020-01007-5

PubMed Abstract | Crossref Full Text | Google Scholar

24. Katzmarzyk PT, Church TS, Craig CL, Bouchard C. Sitting time and mortality from all causes, cardiovascular disease, and cancer. Med Sci Sports Exerc. (2009) 41(5):998–1005. doi: 10.1249/MSS.0b013e3181930355

PubMed Abstract | Crossref Full Text | Google Scholar

25. Patel AV, Bernstein L, Deka A, Feigelson HS, Campbell PT, Gapstur SM, et al. Leisure time spent sitting in relation to total mortality in a prospective cohort of US adults. Am J Epidemiol. (2010) 172(4):419–29. doi: 10.1093/aje/kwq155

PubMed Abstract | Crossref Full Text | Google Scholar

26. Zhou H, Nie J, Cao Y, Diao L, Zhang X, Li J, et al. Association of daily sitting time and coffee consumption with the risk of all-cause and cardiovascular disease mortality among US adults. BMC Public Health. (2024) 24(1):1069. doi: 10.1186/s12889-024-18515-9

PubMed Abstract | Crossref Full Text | Google Scholar

27. Andrade C. Physical exercise and health, 5: sedentary time, independent of health-related physical activity, as a risk factor for adverse physical health and mental health outcomes. J Clin Psychiatry. (2024) 85(1):24f15261. doi: 10.4088/JCP.24f15261

PubMed Abstract | Crossref Full Text | Google Scholar

28. Yu Y, Cheng S, Huang H, Deng Y, Cai C, Gu M, et al. Joint association of sedentary behavior and vitamin D status with mortality among cancer survivors. BMC Med. (2023) 21(1):411. doi: 10.1186/s12916-023-03118-9

PubMed Abstract | Crossref Full Text | Google Scholar

29. Ekelund U, Brown WJ, Steene-Johannessen J, Fagerland MW, Owen N, Powell KE, et al. Do the associations of sedentary behaviour with cardiovascular disease mortality and cancer mortality differ by physical activity level? A systematic review and harmonised meta-analysis of data from 850 060 participants. Br J Sports Med. (2019) 53(14):886–94. doi: 10.1136/bjsports-2017-098963

PubMed Abstract | Crossref Full Text | Google Scholar

30. Lan L, Lang X, McKee M, Tse LA, Rangarajan S, Qiang D, et al. Association of sitting time with cardiovascular events among manual and non-manual workers: a prospective cohort study (PURE-China). BMC Public Health. (2025) 25(1):750. doi: 10.1186/s12889-025-21948-5

PubMed Abstract | Crossref Full Text | Google Scholar

31. Holtermann A, Krause N, van der Beek AJ, Straker L. The physical activity paradox: six reasons why occupational physical activity (OPA) does not confer the cardiovascular health benefits that leisure time physical activity does. Br J Sports Med. (2018) 52(3):149–50. doi: 10.1136/bjsports-2017-097965

PubMed Abstract | Crossref Full Text | Google Scholar

32. Dalene KE, Tarp J, Ekelund U. The role of occupational physical activity on longevity—authors’ reply. Lancet Public Health. (2021) 6(8):e545. doi: 10.1016/S2468-2667(21)00155-9

PubMed Abstract | Crossref Full Text | Google Scholar

33. Tu D, Xu Q, Sun J, Zuo X, Ma C. Joint association of anti-inflammatory diet and vigorous leisure-time physical activity on all-cause and cardiovascular disease mortality in U.S. Adults: findings from NHANES, 2007–2014. Eur J Nutr. (2024) 64(1):45. doi: 10.1007/s00394-024-03558-w

PubMed Abstract | Crossref Full Text | Google Scholar

34. Huang Z, Zhuang X, Huang R, Liu M, Xu X, Fan Z, et al. Physical activity and weight loss among adults with type 2 diabetes and overweight or obesity: a post hoc analysis of the Look AHEAD trial. JAMA Netw Open. (2024) 7(2):e240219. doi: 10.1001/jamanetworkopen.2024.0219

PubMed Abstract | Crossref Full Text | Google Scholar

35. Liao J, Hu M, Imm K, Holmes CJ, Zhu J, Cao C, et al. Association of daily sitting time and leisure-time physical activity with body fat among U.S. adults. J Sport Health Sci. (2024) 13(2):195–203. doi: 10.1016/j.jshs.2022.10.001

PubMed Abstract | Crossref Full Text | Google Scholar

36. Ainsworth BE. Commentary on “association of daily sitting time and leisure-time physical activity with body fat among U.S. adults”. J Sport Health Sci. (2024) 13(2):127–9. doi: 10.1016/j.jshs.2023.09.002

PubMed Abstract | Crossref Full Text | Google Scholar

37. Larsen BA, Allison MA, Kang E, Saad S, Laughlin GA, Araneta MR, et al. Associations of physical activity and sedentary behavior with regional fat deposition. Med Sci Sports Exerc. (2014) 46(3):520–8. doi: 10.1249/MSS.0b013e3182a77220

PubMed Abstract | Crossref Full Text | Google Scholar

38. Schuna JM Jr, Johnson WD, Tudor-Locke C. Adult self-reported and objectively monitored physical activity and sedentary behavior: NHANES 2005–2006. Int J Behav Nutr Phys Act. (2013) 10:126. doi: 10.1186/1479-5868-10-126

PubMed Abstract | Crossref Full Text | Google Scholar

Keywords: cardiovascular disease, leisure-time physical activity, daily sitting time, mortality, cohort study

Citation: Xu C, Jin K, Sun Y, Cai M, Zhu J and Yang Y (2025) Leisure-time physical activity, daily sitting time, and risk of mortality among CVD patients: a prospective cohort study. Front. Cardiovasc. Med. 12:1672135. doi: 10.3389/fcvm.2025.1672135

Received: 24 July 2025; Accepted: 22 September 2025;
Published: 2 October 2025.

Edited by:

Francisco Pitanga, Federal University of Bahia (UFBA), Brazil

Reviewed by:

Zhi-de Liang, Qingdao University, China
Garrett Steinbrink, The University of Iowa, United States

Copyright: © 2025 Xu, Jin, Sun, Cai, Zhu and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yi Yang, aHh5YW5neWkxMjNAMTYzLmNvbQ==

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.